We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




New Guidance Recommends Coronary CTA as First-Line Test when Treating Acute Chest Pain in ED

By HospiMedica International staff writers
Posted on 04 Oct 2022
Print article
Image: New guidance standardizes care for patients presenting with acute chest pain in the ED (Photo courtesy of Pexels)
Image: New guidance standardizes care for patients presenting with acute chest pain in the ED (Photo courtesy of Pexels)

Diagnosis and triage of emergency department (ED) patients with suspected acute coronary syndrome (ACS) consume a large and increasing amount of healthcare resources. ED overcrowding is associated with adverse outcomes for acute chest pain (ACP) patients, and consequently rapid triage has both health and economic consequences. Further, the consequences of missing ACS are both a source of morbidity and mortality in such patients and remain a source of significant malpractice litigation. Therefore, expeditious, safe evaluation of ACP is a pressing need to increase ED efficiency, contain costs and improve outcomes. Coronary computed tomographic angiography (CCTA) is a proven strategy to safely expedite diagnosis and limit resource utilization for patients presenting with acute chest pain in the ED with no known prior coronary artery disease. The clinical value of CCTA in this setting is well-validated in numerous randomized-controlled trials.

The Society of Cardiovascular Computed Tomography (SCCT, Arlington, VA, USA) has now released an expert consensus document detailing standards of practice for CCTA use for patients presenting with ACP to the ED. Endorsed by the American College of Radiology (ACR, Reston, VA, USA) and the North American Society for Cardiovascular Imaging (NASCI, East Dundee, IL, USA), the document outlines the benefits of CCTA as the first-line test for ACP and provides recommendations for appropriate patient selection, preparation, protocol selection, interpretation, reporting and patient management based on clinical evidence and expert consensus.

The guidance is supported by data from eight randomized controlled trials and five meta-analyses validating the utility of CCTA in the ED. Over the past decade, CCTA has established itself as a first-line imaging strategy for rapid triage of patients with low-to-intermediate risk ACP in the ED. CCTA offers rapid evaluation of the degree of coronary stenosis and atherosclerosis, allows significant reduction in time-to-discharge, and ensures high risk patients are appropriately triaged to cardiac catheterization.

Rapid chest pain triage also limits nosocomial infection transmission between patients and medical staff, which is of particular importance during the COVID-era. In the ED setting, the high accuracy of CCTA is driven by its high sensitivity and negative predictive value for detecting or excluding obstructive coronary artery disease, particularly among patients with low-to-intermediate pretest risk for ACS. CCTA is now a recognized frontline test for ACP triage, endorsed with the highest possible rating (Class I, Level of Evidence A) in the 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain

"This document serves as a framework for hospitals and emergency departments looking to implement and expand their coronary CTA programs,” said Christopher Maroules, MD, FSCCT, lead author. “With the detailed operational guidelines and best practices outlined in this document, physicians and administrators will be equipped to leverage the maximum value of this pathway, improving health outcomes for their patients, decompressing busy emergency rooms and lowering healthcare costs. We've finally passed the inflection point where coronary CTA can be considered the new ‘standard of care’ for acute chest pain triage in patients with low-to-intermediate risk for acute coronary syndrome (ACS)."

Related Links:
SCCT
ACR
NASCI 

New
Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Blood Warmer
SAHARA-III 230 V
New
Eye Protector
Biliband
New
Mobile Radiography System
NeuVision 550M (Plus)

Print article

Channels

AI

view channel
Image: MyoVista Wavelet technology utilizes AI for early detection of heart disease (Photo courtesy of Heart Test Laboratories)

Novel ECG Technology Utilizes AI for Early Detection of Heart Disease

Cardiovascular disease is responsible for 17.9 million deaths every year, or about 32% of all deaths worldwide. Every week, millions of electrocardiographs (ECGs) are performed across the world, making... Read more

Critical Care

view channel
Image: Studies have shown the Autus Valve maintains control of blood flow as it expands (Photo courtesy of Boston Children’s Hospital)

Heart Valve That Grows Along With Child Could Reduce Invasive Surgeries

In children with congenital pulmonary valve disease, the flow of blood between the heart and lungs is impeded. In cases where the pulmonary valves have narrowed or are leaking and cannot be treated effectively... Read more

Surgical Techniques

view channel
Image: The LithoVue Elite System (Photo courtesy of Boston Scientific)

First Ever Ureteroscope System Monitors Intrarenal Pressure in Real-Time During Ureteroscopy Procedures

About one in 10 people can develop a kidney stone at some point in their lives. Ureteroscopy is commonly performed by urologists to diagnose and treat various problems in the urinary tract, particularly... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.